Certified by Founder Lodge
Renasant Bio
United States - Berkeley, California
START UP
1 Disclosed Funding Rounds $54,500,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments for autosomal dominant polycystic kidney disease (ADPKD), the leading genetic cause of
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 11 ,2025 | Seed | $54,500,000 |
Atlas Ventures
5AM Ventures
Qiming Venture Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Revel(US) | $150,000,000 | (Feb 27, 2026)
Bluprynt | $4,250,000 | (Feb 27, 2026)
VITURE | $100,000,000 | (Feb 27, 2026)
ElastixAI | $18,000,000 | (Feb 27, 2026)
UpGuard | $75,000,000 | (Feb 27, 2026)
